AI-driven Characterization of Solid Pulmonary Nodules on CT Imaging for Enhanced Malignancy Prediction in Small-sized Lung Adenocarcinoma

IF 3.3 3区 医学 Q2 ONCOLOGY
Yujin Kudo , Taiyo Nakamura , Jun Matsubayashi , Akimichi Ichinose , Yushi Goto , Ryosuke Amemiya , Jinho Park , Yoshihisa Shimada , Masatoshi Kakihana , Toshitaka Nagao , Tatsuo Ohira , Jun Masumoto , Norihiko Ikeda
{"title":"AI-driven Characterization of Solid Pulmonary Nodules on CT Imaging for Enhanced Malignancy Prediction in Small-sized Lung Adenocarcinoma","authors":"Yujin Kudo ,&nbsp;Taiyo Nakamura ,&nbsp;Jun Matsubayashi ,&nbsp;Akimichi Ichinose ,&nbsp;Yushi Goto ,&nbsp;Ryosuke Amemiya ,&nbsp;Jinho Park ,&nbsp;Yoshihisa Shimada ,&nbsp;Masatoshi Kakihana ,&nbsp;Toshitaka Nagao ,&nbsp;Tatsuo Ohira ,&nbsp;Jun Masumoto ,&nbsp;Norihiko Ikeda","doi":"10.1016/j.cllc.2024.04.015","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Distinguishing solid nodules from nodules with ground-glass lesions in lung cancer is a critical diagnostic challenge, especially for tumors ≤2 cm. Human assessment of these nodules is associated with high inter-observer variability, which is why an objective and reliable diagnostic tool is necessary. This study focuses on artificial intelligence (AI) to automatically analyze such tumors and to develop prospective AI systems that can independently differentiate highly malignant nodules.</p></div><div><h3>Materials and methods</h3><p>Our retrospective study analyzed 246 patients who were diagnosed with negative clinical lymph node metastases (cN0) using positron emission tomography-computed tomography (PET/CT) imaging and underwent surgical resection for lung adenocarcinoma. AI detected tumor sizes ≤2 cm in these patients. By utilizing AI to classify these nodules as solid (AI_solid) or non-solid (non-AI_solid) based on confidence scores, we aim to correlate AI determinations with pathological findings, thereby advancing the precision of preoperative assessments.</p></div><div><h3>Results</h3><p>Solid nodules identified by AI with a confidence score ≥0.87 showed significantly higher solid component volumes and proportions in patients with AI_solid than in those with non-AI_solid, with no differences in overall diameter or total volume of the tumors. Among patients with AI_solid, 16% demonstrated lymph node metastasis, and a significant 94% harbored invasive adenocarcinoma. Additionally, 44% were upstaging postoperatively. These AI_solid nodules represented high-grade malignancies.</p></div><div><h3>Conclusion</h3><p>In small-sized lung cancer diagnosed as cN0, AI automatically identifies tumors as solid nodules ≤2 cm and evaluates their malignancy preoperatively. The AI classification can inform lymph node assessment necessity in sublobar resections, reflecting metastatic potential.</p></div>","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S152573042400069X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Distinguishing solid nodules from nodules with ground-glass lesions in lung cancer is a critical diagnostic challenge, especially for tumors ≤2 cm. Human assessment of these nodules is associated with high inter-observer variability, which is why an objective and reliable diagnostic tool is necessary. This study focuses on artificial intelligence (AI) to automatically analyze such tumors and to develop prospective AI systems that can independently differentiate highly malignant nodules.

Materials and methods

Our retrospective study analyzed 246 patients who were diagnosed with negative clinical lymph node metastases (cN0) using positron emission tomography-computed tomography (PET/CT) imaging and underwent surgical resection for lung adenocarcinoma. AI detected tumor sizes ≤2 cm in these patients. By utilizing AI to classify these nodules as solid (AI_solid) or non-solid (non-AI_solid) based on confidence scores, we aim to correlate AI determinations with pathological findings, thereby advancing the precision of preoperative assessments.

Results

Solid nodules identified by AI with a confidence score ≥0.87 showed significantly higher solid component volumes and proportions in patients with AI_solid than in those with non-AI_solid, with no differences in overall diameter or total volume of the tumors. Among patients with AI_solid, 16% demonstrated lymph node metastasis, and a significant 94% harbored invasive adenocarcinoma. Additionally, 44% were upstaging postoperatively. These AI_solid nodules represented high-grade malignancies.

Conclusion

In small-sized lung cancer diagnosed as cN0, AI automatically identifies tumors as solid nodules ≤2 cm and evaluates their malignancy preoperatively. The AI classification can inform lymph node assessment necessity in sublobar resections, reflecting metastatic potential.

Abstract Image

Abstract Image

人工智能驱动的 CT 成像肺实性结节特征描述,用于增强对小尺寸肺腺癌的恶性程度预测
区分肺癌实性结节和磨玻璃样病变结节是一项重要的诊断挑战,尤其是对于≤2 厘米的肿瘤。人类对这些结节的评估与观察者之间的高变异性有关,因此需要一种客观可靠的诊断工具。本研究的重点是利用人工智能(AI)自动分析这类肿瘤,并开发能独立区分高度恶性结节的前瞻性人工智能系统。我们的回顾性研究分析了 246 名通过正电子发射断层扫描-计算机断层扫描(PET/CT)成像确诊为临床淋巴结转移阴性(cN0)并接受肺腺癌手术切除的患者。人工智能检测到这些患者的肿瘤大小≤2 厘米。我们利用人工智能根据置信度评分将这些结节分为实性(人工智能_实性)和非实性(非人工智能_实性),目的是将人工智能测定结果与病理结果联系起来,从而提高术前评估的精确度。通过可信度评分≥0.87的AI确定的实性结节显示,AI_实性患者的实性成分体积和比例明显高于非AI_实性患者,但肿瘤的总直径或总体积没有差异。在有AI_solid的患者中,16%有淋巴结转移,94%有浸润性腺癌。此外,44%的患者在术后出现上行转移。这些AI_solid结节代表了高级别恶性肿瘤。对于诊断为 cN0 的小型肺癌,人工智能可自动识别肿瘤为≤2 厘米的实性结节,并在术前评估其恶性程度。人工智能分类可为肺叶下切除术的淋巴结评估提供必要信息,反映转移的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical lung cancer
Clinical lung cancer 医学-肿瘤学
CiteScore
7.00
自引率
2.80%
发文量
159
审稿时长
24 days
期刊介绍: Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信